ARCHIVES

Seer Gets Extra $5000,000 to Permit Addition Of One Registry To Braden Coverage Of Blacks, Hispanics

This article is from The Cancer Letter archive.

Vol. 08 No. 41 | October 22, 1982

Download PDF Visit The Full Archive

Related Articles

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011